OTCMKTS:BSTG - Biostage Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $2.40 +0.05 (+2.13 %) (As of 02/22/2019 04:00 PM ET)Previous Close$2.35Today's Range$2.40 - $2.4052-Week Range$1.91 - $5.85Volume134 shsAverage Volume2,288 shsMarket Capitalization$14.81 millionP/E RatioN/ADividend YieldN/ABeta2.58 ProfileDiscussionChartEarningsFinancialsInsider TradesHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Biostage, Inc., a biotechnology company, engages in developing bioengineered organ implants based on its Cellframe technology. The company's Cellframe technology combines a proprietary biocompatible scaffold with a patient's own stem cells to create Cellspan organ implants. It is developing bioengineered organ implants, which addresses the damage of the esophagus, bronchus, and trachea due to cancer, infection, trauma, or congenital abnormalities. The company was formerly known as Harvard Apparatus Regenerative Technology, Inc. and changed its name to Biostage, Inc. in March 2016. Biostage, Inc. was founded in 2007 and is headquartered in Holliston, Massachusetts. Receive BSTG News and Ratings via Email Sign-up to receive the latest news and ratings for BSTG and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:BSTG Previous Symbol CUSIPN/A CIK1563665 Webwww.biostage.com Phone774-233-7300Debt Debt-to-Equity RatioN/A Current Ratio4.19 Quick Ratio4.19Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$80,000.00 Price / Sales185.10 Cash FlowN/A Price / Cash FlowN/A Book Value$0.78 per share Price / Book3.08Profitability EPS (Most Recent Fiscal Year)N/A Net Income$-11,910,000.00 Net MarginsN/A Return on Equity-224.68% Return on Assets-138.88%Miscellaneous Employees5 Outstanding Shares6,170,000Market Cap$14.81 million Next Earnings Date4/1/2019 (Estimated) OptionableNot Optionable Biostage (OTCMKTS:BSTG) Frequently Asked Questions What is Biostage's stock symbol? Biostage trades on the OTCMKTS under the ticker symbol "BSTG." When is Biostage's next earnings date? Biostage is scheduled to release their next quarterly earnings announcement on Monday, April 1st 2019. View Earnings Estimates for Biostage. Has Biostage been receiving favorable news coverage? News coverage about BSTG stock has trended positive recently, according to InfoTrie Sentiment. The research group identifies negative and positive news coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Biostage earned a news impact score of 2.7 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the company's share price in the near term. Who are some of Biostage's key competitors? Some companies that are related to Biostage include Repro-Med Systems (REPR), Endologix (ELGX), Obalon Therapeutics (OBLN), AIT Therapeutics (AITB), Nephros (NEPH), Restoration Robotics (HAIR), PAVmed (PAVM), Interpace Diagnostics Group (IDXG), SANUWAVE Health (SNWV), Lianluo Smart (LLIT), DarioHealth (DRIO), Neovasc (NVCN), Dynatronics (DYNT), Hancock Jaffe Laboratories (HJLI) and Invivo Therapeutics (NVIV). What other stocks do shareholders of Biostage own? Based on aggregate information from My MarketBeat watchlists, some companies that other Biostage investors own include Ampliphi Biosciences (APHB), Allena Pharmaceuticals (ALNA), Wheeler Real Estate Investment Trust (WHLR), Fate Therapeutics (FATE), Aurora Cannabis (ACBFF), Sienna Biopharmaceuticals (SNNA), Veru (VERU), Monaker Group (MKGI), Clearside Biomedical (CLSD) and Mirati Therapeutics (MRTX). Who are Biostage's key executives? Biostage's management team includes the folowing people: Mr. James J. McGorry, CEO & Director (Age 63)Mr. Thomas W. McNaughton, CFO & Sec. (Age 59)Yu Hong, Pres (Age 47)Ms. Ginger A. Abraham-Freel, Director of Quality & OperationsDr. William L. Fodor Ph.D., Chief Scientific Officer How do I buy shares of Biostage? Shares of BSTG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Biostage's stock price today? One share of BSTG stock can currently be purchased for approximately $2.40. How big of a company is Biostage? Biostage has a market capitalization of $14.81 million and generates $80,000.00 in revenue each year. Biostage employs 5 workers across the globe. What is Biostage's official website? The official website for Biostage is http://www.biostage.com. How can I contact Biostage? Biostage's mailing address is 84 October Hill Road Suite 11, Holliston MA, 01746. The company can be reached via phone at 774-233-7300 or via email at [email protected] MarketBeat Community Rating for Biostage (OTCMKTS BSTG)Community Ranking: 3.3 out of 5 ( )Outperform Votes: 23 (Vote Outperform)Underperform Votes: 12 (Vote Underperform)Total Votes: 35MarketBeat's community ratings are surveys of what our community members think about Biostage and other stocks. Vote "Outperform" if you believe BSTG will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BSTG will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/22/2019 by MarketBeat.com StaffFeatured Article: What are gap-down stocks?